NCT04098965

Brief Summary

Recruitment of patients who have suffered third- and fourth-degree perineal tear during childbirth, and who have given birth at the Hospital Universitario Marqués de Valdecilla (Santander, Spain). They are distributed randomly in two groups an experimental group who apply techniques of physiotherapy and a control group, receiving medical treatment. At the same time is recruited the same number of patients who have not suffered tear and whose birth has been instrumental, dividing into two groups, control and experimental. And the same number of patients who have given birth but have not suffered tear or instrumental delivery, divided also into control group and experimental.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 20, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2018

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

September 17, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 23, 2019

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2020

Completed
Last Updated

September 23, 2019

Status Verified

September 1, 2019

Enrollment Period

1 year

First QC Date

September 17, 2019

Last Update Submit

September 19, 2019

Conditions

Outcome Measures

Primary Outcomes (4)

  • change in VAS from the start to the end

    Pain

    in the begining, at thirth month, at sixth month and at the finish (one year later)

  • Change in SF36 from de start to the end

    quality of life sorth form

    in the begining, at thirth month, at sixth month and at the finish (one year later)

  • Change in EPIQ from de start to the end

    Epidemiology of Prolapse and Incontinence Questionnaire

    in the begining, at thirth month, at sixth month and at the finish (one year later)

  • Change in OXFORD from the start to the end

    muscle strength

    in the begining, at thirth month, at sixth month and at the finish (one year later)

Study Arms (2)

Experimental

EXPERIMENTAL

Physical Therapy Techniques

Other: Pysiotherapy techniques

Control

OTHER

physician treatment

Other: physician treatment

Interventions

manual therapy techniques, postural re-education and muscle strengthening

Experimental

hygienic-dietary recommendations, Kegel exercises and pain relievers

Control

Eligibility Criteria

Age15 Years - 49 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients who have dysfunctions in the pelvic floor after childbirth
  • Patients who have given birth at the Hospital Universitario Marqués de Valdecilla
  • Patients who do not have any medical alteration that does not indicate the treatment

You may not qualify if:

  • Patients who do not have pelvic floor dysfunctions after childbirth
  • Patients who have not given birth at the Hospital Universitario Marqués de Valdecilla
  • Patients who have any medical changes that counter the treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Sierrallana

Torrelavega, Cantabria, 39300, Spain

RECRUITING

MeSH Terms

Conditions

Pelvic Floor Disorders

Condition Hierarchy (Ancestors)

Female Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPregnancy ComplicationsMale Urogenital Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 17, 2019

First Posted

September 23, 2019

Study Start

July 20, 2017

Primary Completion

July 20, 2018

Study Completion

July 1, 2020

Last Updated

September 23, 2019

Record last verified: 2019-09

Locations